Canopy Growth

NYSE CGC
$9.05 -0.81 -8.95%
Today share price
Canada
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 24 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

750.42M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

1.38B
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

2.14
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

82.92M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

77.10 %

Upcoming events Canopy Growth

All events
No upcoming events scheduled

Stock chart Canopy Growth

Stock analysis Canopy Growth

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-0.62 6.43
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
0.99 4.50
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
13.53 15.79
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
6.17 1.40
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-222.68 19.49

Price change Canopy Growth per year

12.86$ 50.92$
Min Max

Summary analysis Canopy Growth

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Canopy Growth

Revenue and net income Canopy Growth

All parameters

Stock news Canopy Growth

All news

Canopy Growth Narrows Loss on Higher Margins, Lower Sales

Canopy Growth Narrows Loss on Higher Margins, Lower Sales

Canopy Growth seeking shareholder approval for Canopy USA

Canopy Growth to Raise $35M in Private Placement

Canopy Growth to Raise $35M in Private Placement

Toronto Stocks Pare Back; Canopy Growth Slides on $30M Fundraise by Private Placement

Toronto Stocks Pare Back; Canopy Growth Slides on $30M Fundraise by Private Placement

Cannabis company Canopy Growth stock drops after $30M private placement at a discount price

Canopy Growth Shares Down on $30M Private Placement

Canopy Growth Shares Down on $30M Private Placement

Cannabis company Canopy Growth stock drops after $30M private placement at a discount price

Canopy Growth to Raise $30M in Private Placement

Canopy Growth to Raise $30M in Private Placement

Canopy Growth sells BioSteel Canada to Coachwood Group

Martha Stewart launches CBD line with backing from Canopy Growth, Marquee Brands

Canopy Growth’s stock rises after it says it’s found buyers for BioSteel sports drink units

Canopy Growth hits snag with SEC over Canopy USA plan

Canopy Growth’s cash burn raises analyst concerns

Curaleaf and Canopy Growth miss Q3 analyst marks while Ascend Wellness beats forecasts

Canopy Growth Shares Advance 5.2% After Securing Regulatory Certification in EU

About company Canopy Growth

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flowers, oils and concentrates, and softgel capsules. It offers its products under the Tweed, Quatreau, Deep Space, Spectrum Therapeutics, First & Free, TWD, This Works, BioSteel, DNA Genetics CraftGrow, Tokyo Smoke, DOJA, Van der Pop, and Bean & Bud brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada and NHL Alumni Association to examine the efficacy of CBD-based therapies as part of the mitigation of persistent post-concussion symptoms. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
Address:
1 Hershey Drive, Smiths Falls, ON, Canada, K7A 0A8
Company name: Canopy Growth
Issuer ticker: CGC
ISIN: CA1380351009
Country: Canada
Exchange: NYSE
Currency: $
IPO date: 2014-04-04
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://www.canopygrowth.com

On which stock exchange are Canopy Growth (CGC) stocks traded?

Canopy Growth (CGC) stocks are traded on NYSE.

What is the ticker of Canopy Growth stocks (CGC)?

The stock ticker of Canopy Growth’s stocks or in other words, the code is CGC. The stocks are currently listed on the NYSE exchange.

In which sector and industry does Canopy Growth (CGC) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Canopy Growth (CGC) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are Canopy Growth (CGC) stocks traded?

Canopy Growth (CGC) stocks are traded on the NYSE exchange in dollars.

What is the price of Canopy Growth (CGC) stocks today?

The current price of Canopy Growth stocks on 14.05.2024 is 9.05 dollars. per share.

What is the dynamics of Canopy Growth (CGC) stocks from the beginning of the year?

Canopy Growth (CGC) quotes have increased by 88.94% from the beginning of the year up to 9.05 dollars. per 1 stocks.

How much did Canopy Growth (CGC) stocks increase in мае 2024?

This month Canopy Growth (CGC) quotes have increased by -20.89% to 9.05 dollars. per share.

How much are Canopy Growth (CGC) stocks worth?

Today, on October, 14.05.2024 Canopy Growth’s (CGC) stocks cost 9.05 dollars..

What is the market capitalization of Canopy Growth (CGC)?

Capitalization is the market value of Canopy Growth (CGC) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 14.05.2024, the market capitalization of Canopy Growth (CGC) is estimated at about 750418670 dollars.